Koers Henan Taloph Pharmaceutical Stock Co.,Ltd
Aandelen
600222
CNE0000010L8
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,09 CNY | +0,20% | +3,46% | -16,97% |
Omzet 2022 | 1,96 mld. 271 mln. 254 mln. | Omzet 2023 | 2,07 mld. 286 mln. 268 mln. | Marktkapitalisatie | 3,43 mld. 474 mln. 444 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -72 mln. -9,95 mln. -9,33 mln. | Nettowinst (verlies) 2023 | 43 mln. 5,94 mln. 5,57 mln. | EV/omzet 2022 | 1,95 x |
Nettoschuld 2022 | 280 mln. 38,62 mln. 36,21 mln. | Nettoschuld 2023 | 430 mln. 59,4 mln. 55,71 mln. | EV/omzet 2023 | 1,86 x |
K/w-verhouding 2022 |
-49,6
x | K/w-verhouding 2023 |
79,2
x | Werknemers | 2.353 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 69,53% |
1 dag | +0,20% | ||
1 week | +3,46% | ||
Lopende maand | -3,60% | ||
1 maand | -3,60% | ||
3 maanden | -7,12% | ||
6 maanden | -16,28% | ||
Lopend jaar | -16,97% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jing Liang Li
CEO | Chief Executive Officer | 55 | 31-08-07 |
Hai Lin Zhao
DFI | Director of Finance/CFO | 49 | - |
Jian Chao Luo
BRD | Director/Board Member | 51 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jing Liang Li
CEO | Chief Executive Officer | 55 | 31-08-07 |
Xiao Hua Yin
BRD | Director/Board Member | 71 | 09-09-19 |
Zhi Xian Zhang
CHM | Chairman | 51 | 15-11-11 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
30-04-24 | 5,09 | +0,20% | 17 541 600 |
29-04-24 | 5,08 | +1,40% | 25 448 080 |
26-04-24 | 5,01 | -0,79% | 23 475 440 |
25-04-24 | 5,05 | +2,02% | 13 668 360 |
24-04-24 | 4,95 | -2,17% | 17 942 440 |
slotkoers Shanghai S.E., 30 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-16,97% | 393 mln. | |
+32,84% | 704 mld. | |
+28,59% | 577 mld. | |
-3,67% | 348 mld. | |
+18,32% | 327 mld. | |
+5,05% | 288 mld. | |
+14,87% | 234 mld. | |
+4,93% | 198 mld. | |
-9,78% | 194 mld. | |
-4,07% | 147 mld. |